Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy

Abstract

DIPG tumors have neither a highly immunosuppressive nor inflammatory microenvironment. Therefore, major considerations for the development of immunotherapy will be the recruitment, activation, and retention of tumor-specific effector immune cells.